Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher J Graber

Showing results (11-20 of 70) with videos related to

Pageof 7
Sort By:
Emerging Infectious Diseases|May 9, 2020
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease SeverityGlen Huang, Alex J Kovalic, Christopher J Graber
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2011
Inverse correlation of initial CD8 lymphocyte count and CD4 lymphocyte response to combination antiretroviral therapy in treatment-naive HIV-infected patientsNeema Izadi, Matthew Bidwell Goetz, Christopher J Graber
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2026
Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to EvolveChristopher J Graber, Raphael J Landovitz, Westyn Branch-Elliman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2015
Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical PracticeMatthew J Labreche, Christopher J Graber, Hien M Nguyen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2014
Making sense of cephalosporin and amoxicillin/clavulanate susceptibility testing for uropathogensHien M Nguyen, Matthew J Labreche, Christopher J Graber
Journal of Hospital Medicine|January 12, 2010
The top 10 infectious disease pitfalls that hospitalists can avoidNeil M Paige, Sondra S Vazirani, Christopher J Graber
The Journal of Antimicrobial Chemotherapy|November 23, 2013
Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing EnterobacteriaceaeHien M Nguyen, Kileen L Shier, Christopher J Graber
The New England Journal of Medicine|September 7, 2007
Clinical problem-solving. A stitch in time--a 64-year-old man with a history of coronary artery disease and peripheral vascular disease was admitted to the hospital with a several-month history of fevers, chills, and fatigueChristopher J Graber, Adam S Lauring, Peter V Chin-Hong
Annals of Internal Medicine|June 26, 2023
Achieving Equity in Residency and Fellowship Applications With a Partial Blindfold: A Call for Measuring the Distance TraveledTara Vijayan, Christopher J Graber, Christina E Harris, et al.
Open Forum Infectious Diseases|June 23, 2017
Choosing Wisely Overnight? Residents' Approach to FeverJessica Howard-Anderson, Kristin Schwab, Roswell Quinn, et al.
Pageof 7

Showing results (11-20 of 70) with videos related to

Sort By:
Pageof 7
Emerging Infectious Diseases|May 9, 2020
Prognostic Value of Leukocytosis and Lymphopenia for Coronavirus Disease SeverityGlen Huang, Alex J Kovalic, Christopher J Graber
Journal of Acquired Immune Deficiency Syndromes (1999)|December 14, 2011
Inverse correlation of initial CD8 lymphocyte count and CD4 lymphocyte response to combination antiretroviral therapy in treatment-naive HIV-infected patientsNeema Izadi, Matthew Bidwell Goetz, Christopher J Graber
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 26, 2026
Providing the Best Infectious Diseases and Primary Care to Our Patients With HIV: Time for Delivery Models to EvolveChristopher J Graber, Raphael J Landovitz, Westyn Branch-Elliman
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 25, 2015
Recent Updates on the Role of Pharmacokinetics-pharmacodynamics in Antimicrobial Susceptibility Testing as Applied to Clinical PracticeMatthew J Labreche, Christopher J Graber, Hien M Nguyen
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 19, 2014
Making sense of cephalosporin and amoxicillin/clavulanate susceptibility testing for uropathogensHien M Nguyen, Matthew J Labreche, Christopher J Graber
Journal of Hospital Medicine|January 12, 2010
The top 10 infectious disease pitfalls that hospitalists can avoidNeil M Paige, Sondra S Vazirani, Christopher J Graber
The Journal of Antimicrobial Chemotherapy|November 23, 2013
Determining a clinical framework for use of cefepime and β-lactam/β-lactamase inhibitors in the treatment of infections caused by extended-spectrum-β-lactamase-producing EnterobacteriaceaeHien M Nguyen, Kileen L Shier, Christopher J Graber
The New England Journal of Medicine|September 7, 2007
Clinical problem-solving. A stitch in time--a 64-year-old man with a history of coronary artery disease and peripheral vascular disease was admitted to the hospital with a several-month history of fevers, chills, and fatigueChristopher J Graber, Adam S Lauring, Peter V Chin-Hong
Annals of Internal Medicine|June 26, 2023
Achieving Equity in Residency and Fellowship Applications With a Partial Blindfold: A Call for Measuring the Distance TraveledTara Vijayan, Christopher J Graber, Christina E Harris, et al.
Open Forum Infectious Diseases|June 23, 2017
Choosing Wisely Overnight? Residents' Approach to FeverJessica Howard-Anderson, Kristin Schwab, Roswell Quinn, et al.
Pageof 7